Clinical Trials and Translational Medicine Virtual Issue

This virtual issue contains all of the Clinical Trials and Translational Medicine Commentaries published by JPharmSci®

  • Commentary on Fit-For-Purpose Models for Regulatory Applications

    Yaning Wang, Shiew Mei Huang
    Vol. 108, Issue 1, p18–20
  • Physiologically Based Oral Absorption Modelling to Study Gut-Level Drug Interactions

    John Chung, Filippos Kesisoglou
    Vol. 107, Issue 1, p18–23
  • Physiologically Based Pharmacokinetic Modeling of Drug Transporters to Facilitate Individualized Dose Prediction

    Aleksandra Galetin, Ping Zhao, Shiew-Mei Huang
    Vol. 106, Issue 9, p2204–2208
  • In VitroIn Vivo Extrapolation of Metabolism- and Transporter-Mediated Drug–Drug Interactions—Overview of Basic Prediction Methods

    Kenta Yoshida, Ping Zhao, Lei Zhang, Darrell R. Abernethy, Dinko Rekić, Kellie S. Reynolds, Aleksandra Galetin, Shiew-Mei Huang
    Vol. 106, Issue 9, p2209–2213
  • Clinical Drug–Drug Interaction Evaluations to Inform Drug Use and Enable Drug Access

    Dinko Rekić, Kellie S. Reynolds, Ping Zhao, Lei Zhang, Kenta Yoshida, Madhav Sachar, Micheline Piquette Miller, Shiew-Mei Huang, Issam Zineh
    Vol. 106, Issue 9, p2214–2218
  • Recent Trends in Clinical Trials Related to Carrier-Based Drugs

    Tatsuaki Tagami, Tetsuya Ozeki
    Vol. 106, Issue 9, p2219–2226
  • Three-Dimensional Printing of Medicinal Products and the Challenge of Personalized Therapy

    Lucia Zema, Alice Melocchi, Alessandra Maroni, Andrea Gazzaniga
    Vol. 106, Issue 7, p1697–1705
  • The Role of Physiologically Based Oral Absorption Modelling in Formulation Development Under a Quality by Design Paradigm

    Filippos Kesisoglou
    Vol. 106, Issue 4, p944–949
  • Medicines for Pediatric Patients—Biopharmaceutical, Developmental, and Regulatory Considerations

    David P. Elder, René Holm, Martin Kuentz
    Vol. 106, Issue 4, p950–960
  • Maximizing the Impact of Physiologically Based Oral Absorption Modeling and Simulation

    John I. Chung, Ron C. Kelly, Jan Wahlstrom, Benjamin Wu, Tian Wu, Fernando Alvarez-Nunez
    Vol. 106, Issue 3, p734–737
  • The Promises of Quantitative Proteomics in Precision Medicine

    Bhagwat Prasad, Marc Vrana, Aanchal Mehrotra, Katherine Johnson, Deepak Kumar Bhatt
    Vol. 106, Issue 3, p738–744
  • Challenges in Translational Development of Pharmaceutical Cocrystals

    Dnyaneshwar P. Kale, Sandeep S. Zode, Arvind K. Bansal
    Vol. 106, Issue 2, p457–470
  • Midyear Commentary on Trends in Drug Delivery and Clinical Translational Medicine: Growth in Biosimilar (Complex Injectable Drug Formulation) Products Within Evolving Collaborative Regulatory Interagency (FDA, FTC, and DOJ) Practices and Enforcement

    Rodney J.Y. Ho
    Vol. 106, Issue 2, p471–476
  • Past, Present, and Future Drug Delivery Systems for Antiretrovirals

    Ameya R. Kirtane, Robert Langer, Giovanni Traverso
    Vol. 105, Issue 12, p3471–3482
  • Optimizing Clinical Drug Product Performance: Applying Biopharmaceutics Risk Assessment Roadmap (BioRAM) and the BioRAM Scoring Grid

    Paul A. Dickinson, Filippos Kesisoglou, Talia Flanagan, Marilyn N. Martinez, Hitesh B. Mistry, John R. Crison, James E. Polli, Maria T. Cruañes, Abu T.M. Serajuddin, Anette Müllertz, Jack A. Cook, Arzu Selen
    Vol. 105, Issue 11, p3243–3255
  • Trends in Translational Medicine and Drug Targeting and Delivery: New Insights on an Old Concept—Targeted Drug Delivery with Antibody–Drug Conjugates for Cancers

    J.Y. Rodney Ho, Jenny Chien
    Vol. 103, Issue 1, p71–77
  • The Use of Pharmacometrics to Optimize Biosimilar Development

    Mike Dodds, Vincent Chow, Richard Markus, Juan José Pérez-Ruixo, Danny Shen, Megan Gibbs
    Vol. 102, Issue 11, p3908–3914
  • A commentary on transdermal drug delivery systems in clinical trials

    Adam C. Watkinson
    Vol. 102, Issue 9, p3082–3088
  • Back to the Future: Inhaled Drug Products

    Anthony J. Hickey
    Vol. 102, Issue 4, p1165–1172
  • Pharmaceutical Cocrystals: The Coming Wave of New Drug Substances

    Harry G. Brittain
    Vol. 102, Issue 2, p311–317
  • Nanomedicines and Nanodiagnostics Come of Age

    Ijeoma F. Uchegbu, Adeline Siew
    Vol. 102, Issue 2, p305–310
  • The Role of BCS (Biopharmaceutics Classification System) and BDDCS (Biopharmaceutics Drug Disposition Classification System) in Drug Development

    Leslie Z. Benet
    Vol. 102, Issue 1, p34–42
  • Desirable Attributes of Vaccines for Deployment in Low-Resource Settings

    Dexiang Chen, Darin Zehrung
    Vol. 102, Issue 1, p29–33
  • Microdosing: A Critical Assessment of Human Data

    Malcolm Rowland
    Vol. 101, Issue 11, p4067–4074
  • Drug Delivery Trends in Clinical Trials and Translational Medicine: Growth in Biologic Molecule Development and Impact on Rheumatoid Arthritis, Crohn's Disease, and Colitis

    Rodney J.Y. Ho, Jenny Y. Chien
    Vol. 101, Issue 8, p2668–2674
  • Influence of the Compound Selection Process on the Performance of Human Clearance Prediction Methods

    Harvey Wong, Sock-Cheng Lewin-Koh, Frank-Peter Theil, Cornelis E.C.A. Hop
    Vol. 101, Issue 2, p509–515
  • PHRMA CPCDC initiative on predictive models of human pharmacokinetics, part 5: Prediction of plasma concentration–time profiles in human by using the physiologically‐based pharmacokinetic modeling approach

    Patrick Poulin, Rhys D.O. Jones, Hannah M. Jones, Christopher R. Gibson, Malcolm Rowland, Jenny Y. Chien, Barbara J. Ring, Kimberly K. Adkison, M. Sherry Ku, Handan He, Ragini Vuppugalla, Punit Marathe, Volker Fischer, Sandeep Dutta, Vikash K. Sinha, Thorir Björnsson, Thierry Lavé, James W.T. Yates
    Vol. 100, Issue 10, p4127–4157
  • PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 4: Prediction of plasma concentration–time profiles in human from in vivo preclinical data by using the Wajima approach

    Ragini Vuppugalla, Punit Marathe, Handan He, Rhys D.O. Jones, James W.T. Yates, Hannah M. Jones, Christopher R. Gibson, Jenny Y. Chien, Barbara J. Ring, Kimberly K. Adkison, M. Sherry Ku, Volker Fischer, Sandeep Dutta, Vikash K. Sinha, Thorir Björnsson, Thierry Lavé, Patrick Poulin
    Vol. 100, Issue 10, p4111–4126
  • PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 3: Comparative assessement of prediction methods of human clearance

    Barbara J. Ring, Jenny Y. Chien, Kimberly K. Adkison, Hannah M. Jones, Malcolm Rowland, Rhys Do Jones, James W.T. Yates, M. Sherry Ku, Christopher R. Gibson, Handan He, Ragini Vuppugalla, Punit Marathe, Volker Fischer, Sandeep Dutta, Vikash K. Sinha, Thorir Björnsson, Thierry Lavé, Patrick Poulin
    Vol. 100, Issue 10, p4090–4110
  • PhRMA CPCDC Initiative on Predictive Models of Human Pharmacokinetics, Part 1: Goals, Properties of the Phrma Dataset, and Comparison with Literature Datasets

    Patrick Poulin, Hannah M. Jones, Rhys Do Jones, James W.T. Yates, Christopher R. Gibson, Jenny Y. Chien, Barbara J. Ring, Kimberly K. Adkison, Handan He, Ragini Vuppugalla, Punit Marathe, Volker Fischer, Sandeep Dutta, Vikash K. Sinha, Thorir Björnsson, Thierry Lavé, M. Sherry Ku
    Vol. 100, Issue 10, p4050–4073
  • Lead PK Commentary: Predicting Human Pharmacokinetics

    Malcolm Rowland, Leslie Z Benet
    Vol. 100, Issue 10, p4047–4049
  • Drug Delivery Trends in Clinical Trials and Translational Medicine: Evaluation of Pharmacokinetic Properties in Special Populations

    Jenny Y. Chien, Rodney J.Y. Ho
    Vol. 100, Issue 1, p53–58
  • CLINICAL TRIALS AND TRANSLATIONAL MEDICINE COMMENTARY: Drug Delivery Trends in Clinical Trials and Translational Medicine: Challenges and Opportunities in the Delivery of Nucleic Acid-Based Therapeutics

    Long Xu, Thomas Anchordoquy
    Vol. 100, Issue 1, p38–52
  • Prodrugs: Some Thoughts and Current Issues

    Valentino J. Stella
    Vol. 99, Issue 12, p4755–4765
  • Drug delivery trends in clinical trials and translational medicine: Updated analysis of ClinicalTrials.gov database

    Rodney J.Y. Ho, Jenny Y. Chien
    Vol. 98, Issue 6, p1928–1934
  • Drug Delivery Trends in Clinical Trials and Translational Medicine

    Jenny Y. Chien, Rodney J.Y. Ho
    Vol. 97, Issue 7, p2543–2547
Advertisement